“Hot” TME is characterized by a prominent infiltration of CTLs, high expression of PD-L1 on tumor cells, upregulation of antigen-presenting cells (APC) markers, and activation of type 1IFN responses that all help to enhance the response to immunotherapy (13, 14). This evidence concerns the gene CD274 and neoplasm.